Abstract
Background: Identifying simple and reliable prognostic indicators in non-small cell lung cancer (NSCLC) is important to optimize its management. The mean platelet volume/platelet count (MPV/PC) ratio may be of prognostic value in some clinical conditions including NSCLC.Aim: To investigate the relationship between MPV/PC ratio and some important prognostic factors in Egyptian NSCLC patients.Methods: Retrospective study that included 69 patients with stage III/IV NSCLC in the period from January 2010 to December 2012. The complete blood picture done before starting treatment was the one considered for the calculation of MPV/PC. The relation between MPV/PC ratio and patients and disease characteristics was studied.Results: More advanced stage was associated with lower average MPV/PC ratio. The average MPV/PC ratio was 0.45963 (95%CI: 0.38829- 0.53098) in patients with stage IIIA, 0.33873 (95%CI: 0.2854-0.39208) in stage IIIB and 0.32752 (95%CI: 0.28642- 0.36862) in stage IV (p=0.015).Similarly, higher Eastern Cooperative Oncology Group performance status score was associated with lower MPV/PC ratio. The average MPV/PC ratio was 0.40949 (95%CI: 0.34959 – 0.46939) in patients with ECOG 1, 0.36369 (95%CI: 0.31009- 0.41724) in ECOG 2 and 0.28378 (95%CI: 0.24898 -0.31857) in ECOG 3 (p=0.004). Older patients had a significantly lower MPV/PC ratio (p=0.043).Conclusion: Low MPV/PC is associated with poor prognostic factors in NSCLC such as advanced stage and poor performance status. Future clinical studies to evaluate the prognostic value of MPV/PC ration in NSCLC are warranted.
Highlights
We have reviewed all patients' medical records at Clinical Oncology Department, Assuit University Hospital for sex, age, histologic subtype, smoking history, staging and Eastern Cooperative Oncology Group "ECOG" performance status
Lower average mean platelet volume/platelet count (MPV/PC) ratio was associated with more advanced stage (Figure 1)
The average Mean platelet volume (MPV)/PC ratio was 0.45963 (95%CI: 0.38829 -0.53098) in patients with stage IIIA, 0.33873 (95%CI: 0.2854 -0.39208) in patients with stage IIIB and 0.32752 in patients with stage IV (p=0.015)
Summary
Mean platelet volume (MPV) is a platelet volume index[2]. The mean platelet volume/platelet count (MPV/PC) ratio may be of prognostic value in some clinical conditions including NSCLC. Aim: To investigate the relationship between MPV/PC ratio and some important prognostic factors in Egyptian NSCLC patients. The relation between MPV/PC ratio and patients and disease characteristics was studied. Results: More advanced stage was associated with lower average MPV/PC ratio. Higher Eastern Cooperative Oncology Group performance status score was associated with lower MPV/PC ratio. Conclusion: Low MPV/PC is associated with poor prognostic factors in NSCLC such as advanced stage and poor performance status. Future clinical studies to evaluate the prognostic value of MPV/PC ration in NSCLC are warranted.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have